Concepedia

Motoyoshi Tanaka

MT

Statistics

Publications

35

Citations

1.7K

H-Index

24

Active since

1992

Affiliations

Nara Medical University(Current)

The University of Texas MD Anderson Cancer Center

Kindai University

Hokkaido University

University of Florida

Motoyoshi Tanaka is an author at Nara Medical University specializing in oncology, molecular oncology, and medicine.

Publications per year

1992–2018

35

Publications

35

Gelsolin: a candidate for suppressor of human bladder cancer.

Motoyoshi Tanaka, Leonhard Müllauer, Yoshifumi Ogiso et al. · PubMed · 1995 · 187 citations · Full text

, , +12

Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer

Masaki Nogawa, Takeshi Yuasa, Shinya Kimura et al. · Journal of Clinical Investigation · 2005 · 186 citations · Full text

, , +17

A Novel Human AlkB Homologue, ALKBH8, Contributes to Human Bladder Cancer Progression

Keiji Shimada, Mitsutoshi Nakamura, Satoshi Anai et al. · Cancer Research · 2009 · 153 citations · Full text

, , +17

MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells

Motoyoshi Tanaka, Dimpy Koul, Michael A. Davies et al. · Oncogene · 2000 · 100 citations · Full text

, , +14

A Phase I Trial of Vaccination of CA9-Derived Peptides for HLA-A24-Positive Patients with Cytokine-Refractory Metastatic Renal Cell Carcinoma

Hirotsugu Uemura, Kiyohide Fujimoto, Motoyoshi Tanaka et al. · Clinical Cancer Research · 2006 · 89 citations

, , +17

1–5 of 35